What stage does Oriza Seed Capital (Oriza Yuandian) invest at?

Oriza Seed Capital (Oriza Yuandian) invests at the Pre-Seed, Seed, Series A stages.

Where is Oriza Seed Capital (Oriza Yuandian) located?

Oriza Seed Capital (Oriza Yuandian) is headquartered in Suzhou, CN.

Oriza Seed Capital (Oriza Yuandian)

Venture capital

Suzhou · Pre-Seed–Series A · 9 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Oriza Seed Capital (Oriza Yuandian)

Paths you didn't know you had: your email and LinkedIn already hold routes to the Oriza Seed Capital (Oriza Yuandian) team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

Oriza Seed Capital focuses on early-stage investments in technology-driven companies, particularly in information technology, healthcare, semiconductors/IC, AI, intelligent manufacturing, and supply chain sectors. The firm targets high-tech, high-growth SMEs with independent innovation capabilities, incubating them and building industrial chains and high-tech industry clusters. Operating through multiple regional offices across China, it emphasizes deep industry knowledge and hands-on management, having supported numerous companies to domestic and international IPOs.

Invests inAdvanced Manufacturing AI & Machine Learning Biotech Deep Tech Enterprise Software Healthtech Logistics & Supply Chain Robotics Semiconductors Asia-Pacific China Singapore United States

Source: firm website, verified Aug 3, 2026.

Leave your own feedback

Stage

Pre-Seed–Series A

Suzhou, CN

Instruments

Equity

Founded

2001

Team · 9 people

from the firm's website

Jianjiang Fei· General Manager, Managing Partner

A co-founder of Oriza Holdings who has served as its Executive Vice President, General Manager of Sinova Venture Capital, and Co-Chairman of Huayi Fund. With nearly 20 years in venture capital, he focuses on IT and healthcare and has led investments in companies such as Shenzhou Information, Jingfang Technology, Maddie Technology, and Cinda Bio.

Aiying Yang· Guangzhou Regional Partner· Guangzhou

Leads project investment and management in South China. She entered investing in 2008 and previously held roles at Jiuding Investment, CDH Venture Capital, and Yuexiu Industrial Investment, holding a master's degree from Tsinghua University.

Bing Zhu· NanTong Regional Partner· Nantong

Holds a Ph.D. in Mechanical and Electrical Engineering from Nanjing Tech University and an EMBA from Shanghai Jiao Tong University. He joined Oriza Seed in 2014, rising from Investment Manager to Partner, and focuses on advanced technology, industrial technology, and AI, with investments including TZTEK, WeRide, and Cloudwalk.

Ding Zheng· Hangzhou Regional Partner· Hangzhou

Holds a master's in Materials Science from the University of Rochester. He was General Manager of Plug and Play Hangzhou and co-founded Huadao Venture Capital, focusing on early-stage cross-disciplinary technology innovation.

Fei Mi· Beijing Regional Partner· Beijing

Responsible for investment and management in Beijing and surrounding areas and serves as an MBA finance tutor at Cheung Kong Graduate School of Business. He previously worked at the State Administration of Cultural Heritage, Motorola (China), and Meituan, with internet entrepreneurship experience.

Min Du· Suzhou Regional Partner· Suzhou

Has experience across communications, financial payments, and machinery, with expertise in R&D management and brand marketing. He focuses on communications, intelligent manufacturing, and big data investments, working closely with Suzhou-based incubators.

Qun Zhao· Healthcare Partner

Brings 14 years of management experience across chemical, traditional Chinese medicine, biopharmaceutical, and vaccine companies. He has led healthcare investments including Keystone Pharmaceuticals, Ascent Pharmaceuticals, WuXiMing Juno, and Bekom Healthcare.

Wu Di· Partner

Responsible for company operations and risk control and currently Secretary-General of the Suzhou Fund Industry Association. With nearly 20 years in finance, she previously served as Middle and Back Office Partner at Suzhou Fund and Deputy President at Yipu Capital, with a portfolio including Magic Atom, Cybrid Technologies, and Jinhong Gas.

Wenlong Sun· Venture Partner

Responsible for company operations and risk control. A finance doctor from Fudan University and a PRC certified public accountant, he previously worked at UFIDA Software and China UnionPay before joining Oriza Holdings in 2008 to manage equity investment.

Frequently asked questions

What stage does Oriza Seed Capital (Oriza Yuandian) invest at?: Oriza Seed Capital (Oriza Yuandian) invests at the Pre-Seed, Seed, Series A stages.
What sectors does Oriza Seed Capital (Oriza Yuandian) focus on?: Oriza Seed Capital (Oriza Yuandian) focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Deep Tech, Enterprise Software, Healthtech, Logistics & Supply Chain, Robotics, Semiconductors.
Where is Oriza Seed Capital (Oriza Yuandian) located?: Oriza Seed Capital (Oriza Yuandian) is headquartered in Suzhou, CN.

Similar investors

Khosla Ventures

Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.

$100K – $20M

Ankur Capital

Ankur Capital is an early-stage deep science and frontier technology venture firm based in Mumbai, India, backing science- and engineering-driven founders from pre-seed to Series A.

$500K – $2M

Basecamp Fund

A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.